innovative platform technology

Innovative Technology Platform

Entera's innovative technology enables oral drug delivery of large molecules

27163516 pills

Pipeline of Drug Development

Entera conducts clinical trials of three oral drugs based on a proven active compound

27163516 brain green

Experienced Management Team

The managers of Entera have more than 50 years of experience in drug development

September 19, 2011 - Entera completes the first stage in Phase 1 clinical trials for its osteoporosis drug. The trials were carried out at the clinical trials unit at the Hadassah Medical Center in Jerusalem and in addition to the main objective of demonstrating safety in humans the Company expects to receive indications of the drug's bioavalability and its penetration to the vascular system.